NOAEL Studies
Cosmetic Ingredient
2,6-Dimethoxy-3,5-Pyridinediamine HCl NOAEL Studies
INCI: 2,6-DIMETHOXY-3,5-PYRIDINEDIAMINE HCL
CAS: 56216-28-5
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 15 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCP; Jones, J. R.; Pyridinblau I / OEDC 408 90-day oral toxicity study in the rat; SAFEPHARM;09.04.1986 |
| COSMOS DB | NOAEL | 5 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCP; Jones, J. R.; Pyridinblau I / OEDC 408 90-day oral toxicity study in the rat; SAFEPHARM;09.04.1986 |
NTP ICE skin sensitization 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE skin sensitization | EC3 | 6.9 | % | Mouse | Dermal | - | In Vivo; LLNAdb2013; LLNA | sheet=Data_invivo; excel_row=13079; Record_ID=skin_sensitization_invivo_3074; Data_Type=In Vivo; Internal_Data_Source=LLNAdb2013; Mixture=Chemical; DTXSID=DTXSID10892438; Assay=LLNA; Endpoint=EC3; Response=6.9; Response_Unit=%; Species=Mouse; Route=Dermal; Reference=Kern et al. 2010; 20137736; Not available; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID10892438 |
SCCS Opinion 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =5 | mg/kg | human | dermal | 90 day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =10 | mg/kg bw | rabbit | dermal | 90 day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw | - | - | - | NOAEL study | p.19 |
Regulatory source 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 45 | mg/kg bw | - | - | - | - | p.19 |
| Regulatory source | dermal absorption | =5 | mg/kg | human | dermal | 90 day | dermal absorption | p.20 |
| Regulatory source | dermal absorption | 10 | mg/kg bw | rabbit | dermal | 90 day | dermal absorption | p.20 |
| Regulatory source | dermal absorption | 45 | mg/kg bw | rabbit | dermal | 90 day | dermal absorption | p.20 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | H109UIY001 | UNII | - | - | - | chemical | - |